Adhezion Biomedical has introduced the SecurePortIV catheter securement adhesive upon receiving 510(k) clearance from the US Food and Drug Administration (FDA).
SecurePortIV is a highly versatile cyanoacrylate formulation that can be used with short-term or long-term vascular access devices to improve device securement, seal the catheter insertion site, protect the patient from catheter-related bloodstream infection, and offer a water-resistant barrier.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
SecurePortIV is applied to the skin under the hub of vascular access devices and forms a film that holds the catheter to the skin to reduce catheter movement, migration, and/or dislodgment.
Adhezion CEO and chairman Pete Molinaro said: “SecurePortIV is the only cyanoacrylate adhesive in the world that has been cleared by the FDA for use with vascular access devices.
“SecurePortIV has tremendous potential to greatly simplify the care and maintenance of vascular access devices while providing extraordinary value to healthcare facilities, which can normally be achieved only through the combination of multiple different securement and catheter site management products.”
The product is fitted over the catheter-skin insertion site, forming a seal proven to prevent surface bacteria and fungi from entering the catheter skin entry site. It also provides a moisture-proof barrier.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataSecurePortIV can help minimise the frequency of dressing changes by effectively sealing the catheter insertion site.
